M2Gen, a health informatics solutions company focused on accelerating the discovery, development and delivery of precision medicine, announced today a $3 million donation to fund seven team science research projects as part of the Oncology Research Information Exchange Network® (ORIEN) New Oncologic Visionary Awards (NOVA) program.
Each project will bring together researchers from a variety of leading cancer centers around the country, including ORIEN’s founding members, Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, to address some of cancer’s toughest questions. Each of the awarded projects are led by ORIEN Member institutions, an alliance of key oncology stakeholders dedicated to breaking down the silos that can inhibit discovery and progress.
The ORIEN NOVA program was designed to advance research by encouraging collaborative multidisciplinary team science across the ORIEN members, allowing researchers to share information and expertise, to ultimately improve patient care.
“Cancer is a complicated disease, and no single entity can solve it alone – innovative partnerships and access to data are the keys to answering cancer’s toughest questions,” said William S. Dalton, PhD, MD, Executive Chair of M2Gen. “We’ve initiated the ORIEN NOVA program to give researchers and physician scientists the opportunity to access all of the resources of ORIEN’s research alliance, breaking down barriers between institutions to enable rapid learning and accelerate research efforts and discovery to bring new treatments to patients. Together with the Community Foundation of Tampa Bay, we have setup the ORIEN Foundation in March of this year to support future NOVA awards which will help facilitate ongoing research collaborations across ORIEN members for years to come.” Read more…